Le Jeune Puetz Investment Counsel LLC Bristol Myers Squibb CO Transaction History
Le Jeune Puetz Investment Counsel LLC
- $272 Million
- Q1 2023
A detailed history of Le Jeune Puetz Investment Counsel LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Le Jeune Puetz Investment Counsel LLC holds 13,544 shares of BMY stock, worth $781,217. This represents 0.35% of its overall portfolio holdings.
Number of Shares
13,544
Previous 12,763
6.12%
Holding current value
$781,217
Previous $918,000
2.18%
% of portfolio
0.35%
Previous 0.35%
Shares
10 transactions
Others Institutions Holding BMY
# of Institutions
2,536Shares Held
1.47BCall Options Held
31.6MPut Options Held
35M-
Vanguard Group Inc Valley Forge, PA189MShares$10.9 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.15 Billion0.15% of portfolio
-
State Street Corp Boston, MA92.9MShares$5.36 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY77.9MShares$4.5 Billion0.33% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA61MShares$3.52 Billion0.61% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $123B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...